209 related articles for article (PubMed ID: 27314626)
1. Design, semisynthesis and cytotoxic activity of novel ester derivatives of betulinic acid-1,2,4 oxadiazoles.
Challa K; Bhargavi MV; Krupadanam GL
J Asian Nat Prod Res; 2016 Dec; 18(12):1158-1168. PubMed ID: 27314626
[TBL] [Abstract][Full Text] [Related]
2. Novel semisynthetic derivatives of betulin and betulinic acid with cytotoxic activity.
Santos RC; Salvador JA; Marín S; Cascante M
Bioorg Med Chem; 2009 Sep; 17(17):6241-50. PubMed ID: 19674909
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship study of novel cytotoxic carbamate and N-acylheterocyclic bearing derivatives of betulin and betulinic acid.
Santos RC; Salvador JA; Marín S; Cascante M; Moreira JN; Dinis TC
Bioorg Med Chem; 2010 Jun; 18(12):4385-96. PubMed ID: 20494586
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and cytotoxicity of triterpenoids derived from betulin and betulinic acid via click chemistry.
Shi W; Tang N; Yan WD
J Asian Nat Prod Res; 2015; 17(2):159-69. PubMed ID: 25379995
[TBL] [Abstract][Full Text] [Related]
5. Terpene Esters from Natural Products: Synthesis and Evaluation of Cytotoxic Activity.
Victor MM; David JM; Sakukuma MCK; Costa-Lotufo LV; Moura AF; Araújo AJ
An Acad Bras Cienc; 2017; 89(3):1369-1379. PubMed ID: 28813102
[TBL] [Abstract][Full Text] [Related]
6. New ursolic and betulinic derivatives as potential cytotoxic agents.
Baglin I; Poumaroux A; Nour M; Tan K; Mitaine-Offer AC; Lacaille-Dubois MA; Chauffert B; Cavé C
J Enzyme Inhib Med Chem; 2003 Apr; 18(2):111-7. PubMed ID: 12943194
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticancer activity of novel betulinic acid and betulin derivatives.
Kommera H; Kaluderović GN; Kalbitz J; Paschke R
Arch Pharm (Weinheim); 2010 Aug; 343(8):449-57. PubMed ID: 20726008
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic activity of 17-carboxylic acid modified 23-hydroxy betulinic acid ester derivatives.
Bi Y; Xu J; Wu X; Ye W; Yuan S; Zhang L
Bioorg Med Chem Lett; 2007 Mar; 17(5):1475-8. PubMed ID: 17275295
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxic activity of heterocyclic ring-substituted betulinic acid derivatives.
Kumar V; Rani N; Aggarwal P; Sanna VK; Singh AT; Jaggi M; Joshi N; Sharma PK; Irchhaiya R; Burman AC
Bioorg Med Chem Lett; 2008 Sep; 18(18):5058-62. PubMed ID: 18752941
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of phthalates of betulinic acid and betulin with cytotoxic activity.
Kvasnica M; Sarek J; Klinotova E; Dzubak P; Hajduch M
Bioorg Med Chem; 2005 May; 13(10):3447-54. PubMed ID: 15848757
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid.
Gu W; Jin XY; Li DD; Wang SF; Tao XB; Chen H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4128-4132. PubMed ID: 28733083
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxicity of betulin and betulinic acid derived 30-oxo-amides.
Kozubek M; Hoenke S; Schmidt T; Deigner HP; Al-Harrasi A; Csuk R
Steroids; 2022 Jun; 182():109014. PubMed ID: 35314417
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
Kumar D; Patel G; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and studies of anticancer properties of lupane-type triterpenoid derivatives containing a cisplatin fragment.
Emmerich D; Vanchanagiri K; Baratto LC; Schmidt H; Paschke R
Eur J Med Chem; 2014 Mar; 75():460-6. PubMed ID: 24561674
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of A-seco derivatives of betulinic acid with cytotoxic activity.
Urban M; Sarek J; Klinot J; Korinkova G; Hajduch M
J Nat Prod; 2004 Jul; 67(7):1100-5. PubMed ID: 15270560
[TBL] [Abstract][Full Text] [Related]
16. Betulinic Acid and its Derivatives as Potential Antitumor Agents.
Zhang DM; Xu HG; Wang L; Li YJ; Sun PH; Wu XM; Wang GJ; Chen WM; Ye WC
Med Res Rev; 2015 Nov; 35(6):1127-55. PubMed ID: 26032847
[TBL] [Abstract][Full Text] [Related]
17. Development of C-20 modified betulinic acid derivatives as antitumor agents.
Kim JY; Koo HM; Kim DS
Bioorg Med Chem Lett; 2001 Sep; 11(17):2405-8. PubMed ID: 11527742
[TBL] [Abstract][Full Text] [Related]
18. A review of natural and modified betulinic, ursolic and echinocystic acid derivatives as potential antitumor and anti-HIV agents.
Baglin I; Mitaine-Offer AC; Nour M; Tan K; Cavé C; Lacaille-Dubois MA
Mini Rev Med Chem; 2003 Sep; 3(6):525-39. PubMed ID: 12871156
[TBL] [Abstract][Full Text] [Related]
19. A 3D-QSAR Study on Betulinic Acid Derivatives as Anti-Tumor Agents and the Synthesis of Novel Derivatives for Modeling Validation.
Ding W; Zhang S; Zhu M; Wang S; Xu T; Qu H; Yu T; Yan X; Wang Y
Anticancer Agents Med Chem; 2017; 17(4):566-575. PubMed ID: 27658994
[TBL] [Abstract][Full Text] [Related]
20. Betulinic Acid-Nitrogen Heterocyclic Derivatives: Design, Synthesis, and Antitumor Evaluation
Yang Y; Xie T; Tian X; Han N; Liu X; Chen H; Qi J; Gao F; Li W; Wu Q; Huo S; Gu Y; Dai Z; Wang P; Lei H
Molecules; 2020 Feb; 25(4):. PubMed ID: 32093264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
